J. Ravkilde

C. Terkelsen, O. Havndrup, J. Ravkilde, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.

J. Jeppesen, J. Jensen, T. Engstrøm, 2017, Journal of the American College of Cardiology.

Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.

A. Kaltoft, M. Maeng, J. Ravkilde, 2016, Journal of the American College of Cardiology.

A 10‐month angiographic and 4‐year clinical outcome of everolimus‐eluting versus sirolimus‐eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)

A. Kaltoft, M. Maeng, J. Ravkilde, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

A. Kaltoft, H. Sørensen, M. Maeng, 2015, The American journal of cardiology.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

C. Terkelsen, H. Bøtker, A. Kaltoft, 2013, JACC. Cardiovascular interventions.

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.

L. Newby, C. Cannon, D. Morrow, 2008, Clinical biochemistry.

Practice Guidelines : Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS

L. Newby, C. Cannon, D. Morrow, 2007 .

Patient delay in patients with ST-elevation myocardial infarction: Time patterns and predictors for a prolonged delay

C. Terkelsen, J. Ravkilde, S. Kristensen, 2017, European heart journal. Acute cardiovascular care.

Consultant or Advisory Role: None declared. Stock Ownership: None declared.

L. Newby, J. Ravkilde, Storrow Ab, 2012 .

Quality assurance of the Western Denmark Heart Registry, a population-based healthcare register.

H. Bøtker, J. Andreasen, J. Ravkilde, 2017, Danish medical journal.

Syddansk Universitet Quality assurance of the Western Denmark heart registry, a population-based healthcare register Rasmussen,

H. Bøtker, J. Andreasen, J. Ravkilde, 2017 .

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Scott A. Prentice, B. Prendergast, C. Terkelsen, 2019, The Lancet.

Primary Percutaneous Coronary Intervention as a National Reperfusion Strategy in Patients With ST-Segment Elevation Myocardial Infarction

C. Terkelsen, J. Ravkilde, J. Lassen, 2011, Circulation. Cardiovascular interventions.

National academy of clinical biochemistry laboratory medicine practice guidelines: Point of care testing, oversight, and administration of cardiac biomarkers for acute coronary syndromes

L. Newby, C. Cannon, D. Morrow, 2007 .

2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial.

H. Bøtker, A. Kaltoft, M. Maeng, 2012, Journal of the American College of Cardiology.

Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.

C. Terkelsen, H. Bøtker, A. Kaltoft, 2008, Journal of the American College of Cardiology.

Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris.

J. Ravkilde, P. Andersen, M. Hørder, 1994, American heart journal.

Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest--a systematic review and meta-analysis.

J. Ravkilde, J. Larsen, 2012, Resuscitation.

Risk Stratification of Acute Coronary Syndrome Patients. A Multi‐Marker Approach

J. Ravkilde, 2005, Scandinavian journal of clinical and laboratory investigation. Supplementum.

PEER REVIEWED PUBLICATIONS 1. Ali YS, Maron DJ. Screening for coronary disease in diabetes: when and how. Clin Diabetes 2006; 24:169- 173.

L. Newby, C. Cannon, D. Morrow, 2007 .

Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays.

P. Venge, J. Ravkilde, S. Hjortshøj, 2011, Clinica chimica acta; international journal of clinical chemistry.

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).

C. Terkelsen, A. Kaltoft, H. Sørensen, 2011, The American journal of cardiology.

Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction.

J. Ravkilde, N. Tryding, M. Hørder, 1993, Scandinavian journal of clinical and laboratory investigation.

A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome

S. Kristensen, J. Ravkilde, S. Hjortshøj, 2011, Scandinavian journal of clinical and laboratory investigation.

Triage of chest pain patients based on early risk stratification using sensitive cardiac markers.

K. Thygesen, J. Ravkilde, 2000, European heart journal.

The SORT OUT III 3-Year Follow-Up 813 The 2 first-generation drug-eluting stents ( DES ) , the Cypher Select

H. Bøtker, A. Kaltoft, J. Jensen, 2012 .

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.

H. Bøtker, A. Kaltoft, H. Sørensen, 2012, JACC. Cardiovascular interventions.

Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction.

K. Thygesen, J. Ravkilde, P. Søgaard, 1992, The American journal of cardiology.

Ventricular Arrhythmias in the Acute and Chronic Phases After Acute Myocardial Infarction: Effect of Intervention With Captopril

K. Thygesen, J. Ravkilde, P. Søgaard, 1994, Circulation.

Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography: a historical cohort study

C. Torp-Pedersen, J. Ravkilde, P. Søgaard, 2017, BMC Cardiovascular Disorders.

Aalborg Universitet Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography a historical cohort study

C. Torp-Pedersen, J. Ravkilde, P. Søgaard, 2017 .

A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study

P. Collinson, J. Suvisaari, J. Ravkilde, 2009, Clinical chemistry and laboratory medicine.

Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers

C. Dethlefsen, S. Kristensen, J. Ravkilde, 2008, Scandinavian journal of clinical and laboratory investigation.

Biochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: Experiences from the Nordic countries

B. Lindahl, J. Ravkilde, K. Pulkki, 2005, Scandinavian cardiovascular journal : SCJ.

Effect of Intervention With Captopril

K. Thygesen, J. Ravkilde, 2005 .

Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia.

C. Dethlefsen, S. Kristensen, J. Ravkilde, 2009, Clinica chimica acta; international journal of clinical chemistry.

S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB.

H. Katus, C. Hamm, J. Ravkilde, 1991, Clinical chemistry.

Human ventricular myosin light chain isotype 1 as a marker of myocardial injury.

K. Thygesen, J. Ravkilde, P. Søgaard, 1994, Cardiology.

Determinants of the release pattern of ischaemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI

C. Dethlefsen, S. Kristensen, J. Ravkilde, 2010, Scandinavian journal of clinical and laboratory investigation.

Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).

H. Bøtker, A. Kaltoft, H. Sørensen, 2011, The American journal of cardiology.

Hemolysis Interference in the Ortho- Clinical Diagnostics Vitros ECi cTnI Assay

F. Dati, J. Ravkilde, W. Gerhardt, 2003 .

Markers in Cardiology: A Case-Orientated Approach. Jesse E. Adams, Fred S. Apple, and Allan S. Jaffe, editors. Malden, MA: Blackwell Futura Publishing, 2007, 261 pp, $99.95. ISBN 978-1-4051-3418-7.

J. Ravkilde, 2008 .

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.

P. Collinson, J. Suvisaari, J. Ravkilde, 2008, Clinical chemistry.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.

C. Terkelsen, H. Bøtker, A. Kaltoft, 2010, Journal of the American College of Cardiology.

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy).

C. Terkelsen, L. Køber, T. Engstrøm, 2018, The American journal of cardiology.

Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study

C. Terkelsen, H. Bøtker, J. Jensen, 2017, European heart journal.

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

Fred S Apple, Robert H Christenson, Christopher P Cannon, 2007, Circulation.

Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results.

M. Niemelä, J. Airaksinen, S. Vikman, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB.

H. Bøtker, K. Thygesen, J. Ravkilde, 1991, British heart journal.

Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.

M. Niemelä, S. Vikman, J. Jensen, 2013, JACC. Cardiovascular interventions.

S-troponin-T as a marker of ischemic myocardial injury.

H. Katus, C. Hamm, J. Ravkilde, 1992, Clinical chemistry.

Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).

A. Kaltoft, H. Sørensen, M. Maeng, 2012, The American journal of cardiology.

Long-term results after simple versus complex stenting of coronary artery bifurcation lesions

M. Niemelä, J. Airaksinen, K. Nikus, 2013 .

Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography A historical cohort

C. Torp-Pedersen, J. Ravkilde, P. Søgaard, 2017 .

Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.

S. Kristensen, J. Ravkilde, S. Hjortshøj, 2010, The American journal of emergency medicine.

Haematoma after Coronary Angiography and Percutaneous Coronary Intervention via the Femoral Artery Frequency and Risk Factors

J. Ravkilde, M. Skriver, Kirsten Andersen, 2005, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Clinical Application of Two Novel Rapid Bedside Tests for the Detection of Cardiac Troponin T and Creatine Kinase-MB Mass/Myoglobin in Whole Blood in Acute Myocardial Infarction

K. Thygesen, J. Ravkilde, M. S. Lüscher, 1998, Cardiology.

Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5-year follow-up study in 156 consecutive patients.

K. Thygesen, J. Ravkilde, M. Hørder, 1992, Cardiology.

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.

Fred S Apple, Mauro Panteghini, Franca Pagani, 2005, Clinical chemistry.

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.

H. Bøtker, M. Maeng, J. Ravkilde, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.

J. Ravkilde, O. Frøbert, U. Simonsen, 2008, International journal of cardiology.

It's time for a change to a troponin standard.

A. Jaffe, F. Apple, H. Katus, 2000, Circulation.

TCT-25 Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting. Five Year Clinical Outcome in The Nordic-Baltic Bifurcation Study III

M. Niemelä, J. Airaksinen, T. Mäkikallio, 2013 .

Exercise capacity in patients with left ventricular dysfunction following acute myocardial infarction: relation to systolic and diastolic function and intervention with captopril.

K. Thygesen, J. Ravkilde, P. Søgaard, 1994, Cardiology.

Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting: The Nordic-Baltic Bifurcation Study III

M. Niemelä, J. Airaksinen, S. Vikman, 2011, Circulation.

Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE)

P. Collinson, J. Suvisaari, J. Ravkilde, 2013, Clinical chemistry and laboratory medicine.

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.

L. Køber, T. Engstrøm, L. Holmvang, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prognostic value of biochemical Markers in Ischaemic Heart Disease

J. Ravkilde, 1998 .

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

J. Hartikainen, H. Sørensen, M. Niemelä, 2016, The Lancet.

Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia.

K. Thygesen, M. Dellborg, J. Ravkilde, 1999, Journal of the American College of Cardiology.

Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia.

K. Thygesen, J. Ravkilde, L. Heickendorff, 1997, Circulation.

Randomized Comparison of Coronary Bifurcation Stenting With the Crush Versus the Culotte Technique Using Sirolimus Eluting Stents: The Nordic Stent Technique Study

M. Niemelä, T. Mäkikallio, J. Jensen, 2009, Circulation. Cardiovascular interventions.

J. Ravkilde, J. Lassen, T. Niemann, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: results from the Danish On-pump Versus Off-pump Randomization Study (DOORS).

K. Houlind, J. Ravkilde, P. Hansen, 2014, The Journal of thoracic and cardiovascular surgery.

Risk stratification in acute coronary syndrome using cardiac troponin I.

J. Ravkilde, 2000, Clinical chemistry.

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

A. Kaltoft, T. Thim, T. Engstrøm, 2012, BMC Cardiovascular Disorders.

Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

C. Terkelsen, A. Kaltoft, H. Sørensen, 2012, The American journal of cardiology.

Highly Sensitive Troponin T in Patients with Acute Ischemic Stroke

S. Kristensen, J. Ravkilde, T. Ueland, 2012, European Neurology.

Quality Specifications for Cardiac Troponin Assays

A. Wu, F. Dati, M. Panteghini, 2001, Clinical chemistry and laboratory medicine.

Quality specifications for B-type natriuretic peptide assays.

A. Jaffe, A. Wu, M. Panteghini, 2005, Clinical chemistry.

Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV)

C. Terkelsen, H. Bøtker, A. Kaltoft, 2012, Circulation.

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.

A. Kaltoft, H. Sørensen, M. Maeng, 2010 .

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

H. Bøtker, A. Kaltoft, H. Sørensen, 2010, The Lancet.

Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial.

H. Bøtker, S. Jensen, M. Maeng, 2015, American heart journal.

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

A. Kaltoft, M. Maeng, J. Ravkilde, 2014, JACC. Cardiovascular interventions.

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial.

H. Bøtker, H. Sørensen, M. Maeng, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2013, The Lancet.

Zotarolimus‐eluting vs. sirolimus‐eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy

A. Kaltoft, H. Sørensen, T. Thim, 2012, European journal of clinical investigation.

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

C. Terkelsen, H. Bøtker, K. Veien, 2017, JACC. Cardiovascular interventions.

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2016, Circulation. Cardiovascular interventions.

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2015, The Lancet.

Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era

J. Ravkilde, S. Riahi, H. Hansen, 2007, Scandinavian cardiovascular journal : SCJ.

Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic(R), Express(R), and Flexmaster(R) coronary stents.

H. Bøtker, J. Ravkilde, S. Kristensen, 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A Modified Treatment Failure Classification System with Complete and Exhaustive Accounting of Any Adverse Events Related to the Previous Percutaneous Coronary Intervention

J. Jeppesen, J. Ravkilde, J. Lassen, 2014 .

Dimensions of Socioeconomic Status and Clinical Outcome After Primary Percutaneous Coronary Intervention

J. Ravkilde, J. Lassen, T. Niemann, 2012, Circulation. Cardiovascular interventions.

Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV

J. Hartikainen, C. Terkelsen, M. Niemelä, 2020, Open Heart.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial

H. Bøtker, A. Kaltoft, H. Sørensen, 2014, The Lancet.

Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2008, Circulation.

Cardiac troponin levels following monitored epileptic seizures

M. Burritt, J. Britton, A. Jaffe, 2003, Neurology.

Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology

C. Terkelsen, H. Bøtker, J. Ravkilde, 2013, Clinical epidemiology.

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.

H. Bøtker, J. Jensen, T. Engstrøm, 2008, JAMA.

Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart Disease

H. Sørensen, J. Ravkilde, J. Lassen, 2010, Cardiology.

Review of Registry and Randomised Comparisons of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents in Western Denmark

C. Terkelsen, H. Bøtker, A. Kaltoft, 2010 .

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation.

A. Kaltoft, H. Sørensen, M. Maeng, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Diabetes on Clinical Outcomes after Revascularization with Everolimus- and Sirolimus-Eluting Stents

A. Kaltoft, H. Sørensen, M. Maeng, 2011 .

Long-term prognosis of non-st-elevation myocardial infarction patients with no obstructive coronary artery disease is worse than patients with one- or two-vessel disease

C. Torp-Pedersen, J. Ravkilde, P. Søgaard, 2017 .

The universal definition of myocardial infarction

Jeroen J. Bax, N. Al-Attar, R. de Caterina, 2015, Oxford Medicine Online.

Universal definition of myocardial infarction.

Jeroen J. Bax, Joseph S Alpert, Kristian Thygesen, 2007 .

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Scott A. Prentice, B. Prendergast, C. Terkelsen, 2019, Lancet.

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

J S Alpert, E. Antman, H. Tunstall-Pedoe, 2000, Journal of the American College of Cardiology.

National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.

Robert H Christenson, Christopher P Cannon, David A Morrow, 2007, Circulation.

National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.

Fred S Apple, Robert H Christenson, Alan H B Wu, 2007, Circulation.

Third universal definition of myocardial infarction

Jeroen J. Bax, P. Kirchhof, D. Atar, 2013, Nature Reviews Cardiology.

[Use of a combined mobile phone and fax solution in the selection of patients with S-elevation acute myocardial infarction].

J. Ravkilde, S. Hjortshøj, 2004, Ugeskrift for læger.

Third universal definition of myocardial infarction

Jeroen J. Bax, Joseph S Alpert, Kristian Thygesen, 2013, Nature Reviews Cardiology.

Late Results Following Closed Mitral Valvotomy in Isolated Mitral Valve Stenosis: Analysis of Thirty-five Years of Follow-up in 240 Patients using Cox Regression

J. Ravkilde, P. Hansen, 1991, The Thoracic and cardiovascular surgeon.

OUTCOMES AFTER REVASCULARIZATION WITH EVEROLIMUS AND SIROLIMUS ELUTING STENTS IN PATIENTS WITH SMALL AND LARGE CORONARY ARTERIES. A SUBSTUDY OF THE SORT OUT IV TRIAL

A. Kaltoft, M. Maeng, J. Ravkilde, 2012 .

Third universal definition of myocardial infarction.

Jeroen J. Bax, E. Antman, G. Filippatos, 2012, Circulation.

Universal definition of myocardial infarction.

Jeroen J. Bax, N. Al-Attar, Jun Zhu, 2007, Circulation.

Third universal definition of myocardial infarction.

Jeroen J. Bax, P. Kirchhof, D. Atar, 2012, Journal of the American College of Cardiology.

Risk stratification in acute coronary syndrome using cardiac troponin I.

J. Ravkilde, 2000, Clinical chemistry.

Third universal definition of myocardial infarction.

Jeroen J. Bax, D. Atar, P. Kolh, 2012, European heart journal.

Universal definition of myocardial infarction.

Jeroen J. Bax, N. Al-Attar, Jun Zhu, 2007, Circulation.

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

L. Newby, C. Cannon, D. Morrow, 2007, Circulation.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

J. Hartikainen, H. Sørensen, M. Niemelä, 2016, The Lancet.

L. Newby, C. Cannon, D. Morrow, 2007, Circulation.

Coronary Heart Disease / Myocardial Infarction Diminished Vascular Response to Inhibition of Endothelium-Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin-1 in Clinically Healthy Smokers

Samin K. Sharma, R. Califf, Jeffrey L. Anderson, 2005 .

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

P. Collinson, J. Suvisaari, J. Ravkilde, 2012, Clinical chemistry.

Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978-2012).

C. Torp‐Pedersen, L. Køber, J. Ravkilde, 2015, European heart journal. Quality of care & clinical outcomes.

C. Terkelsen, H. Bøtker, A. Kaltoft, 2016, Circulation. Cardiovascular interventions.

A. Jaffe, L. Newby, C. Cannon, 2007, Clinical chemistry.

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS

A. Storrow, J. Ravkilde, W. Tang, 2007 .

Practice Guidelines : Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS

A. Storrow, J. Ravkilde, W. Tang, 2007 .

A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome

S. Kristensen, J. Ravkilde, S. Hjortshøj, 2011, Scandinavian journal of clinical and laboratory investigation.

Practice Guidelines : Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes

L. Newby, C. Cannon, D. Morrow, 2007 .

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

A. Kaltoft, M. Maeng, J. Ravkilde, 2014, JACC. Cardiovascular interventions.

Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction.

J. Ravkilde, C. Gøtzsche, K. Thygesen, 1994, American heart journal.

Dimensions of Socioeconomic Status and Clinical Outcome After Primary Percutaneous Coronary Intervention

J. Ravkilde, J. Lassen, T. Niemann, 2012, Circulation. Cardiovascular interventions.

Randomized Comparison of Coronary Bifurcation Stenting With the Crush Versus the Culotte Technique Using Sirolimus Eluting Stents: The Nordic Stent Technique Study

M. Niemelä, T. Mäkikallio, J. Jensen, 2009, Circulation. Cardiovascular interventions.

Creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chain isotype 1 as serological markers of myocardial injury and their prognostic importance in acute coronary syndrome.

J. Ravkilde, 1998, Danish medical bulletin.

Comparison of Paclitaxel- and Sirolimus- Eluting Stents in Everyday Clinical Practice

H. Bøtker, S. Galatius, J. Ravkilde, 2013 .